New Data for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) to be presented at the 2017 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to New Data for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) to be presented at the 2017 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
CARLISLE COMPANIES, Inc. (NYSE: CSL) Delayed: 352.88 -8.08 (2.24%)
Previous Close $360.96    52 Week High $114.49 
Open $354.76    52 Week Low $75.17 
Day High $358.75    P/E 97.75 
Day Low $351.21    EPS $3.61 
Volume 292,152       

(AMEX: CSLLY) Delayed: 19.59 -0.29 (1.46%)
Previous Close $19.88    52 Week High $45.60 
Open $19.50    52 Week Low $33.39 
Day High $19.73    P/E N/A 
Day Low $19.44    EPS $0.00 
Volume 907,368